Editorial Comment to Quantitative Evaluation of Pharmacologic Synergy for Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle‐Invasive Bladder Cancer: A Copula‐Based Secondary Analysis

Makito Miyake
International Journal of Urology · Wiley · 2026-11-04 · DOI: 10.1111/iju.70699

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles